Event Archives - BioAegis Therapeutics

March 27-28, 2025: MedInvest Biotech & Pharma Investor Conference

Susan Serrao — Fri, 07 Mar 2025 18:36:39 +0000

BioAegis COO and Co-founder, Valerie Ceva, was invited to present at the upcoming MedInvest Biotech & Pharma Investor Conference in New York City. The presentation, “Conquering Disease Driven by Excess Inflammation” will highlight BioAegis’ novel, host-directed immune regulator protein. The presentation will also discuss BioAegis’ lead indication, Acute Respiratory Distress Syndrome (ARDS), and its phase […]

The post March 27-28, 2025: MedInvest Biotech & Pharma Investor Conference appeared first on BioAegis Therapeutics.

March 18-21, 2025: 44th Annual International Symposium on Intensive Care and Emergency Medicine (ISICEM)

Susan Serrao — Fri, 07 Mar 2025 06:58:00 +0000

BioAegis is a sponsor of the upcoming International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, Belgium from March 18-21, 2025. Current information on our ongoing ARDS trial will be presented at this key critical care conference.

The post March 18-21, 2025: 44th Annual International Symposium on Intensive Care and Emergency Medicine (ISICEM) appeared first on BioAegis Therapeutics.

September 10-12, 2024: 6th Annual Inflammasome Therapeutics Summit

Susan Serrao — Thu, 05 Sep 2024 18:18:24 +0000

BioAegis CEO and co-founder, Susan Levinson, PhD, will be participating in the upcoming 6th Annual Inflammasome Therapeutics Summit in Boston, MA.

The post September 10-12, 2024: 6th Annual Inflammasome Therapeutics Summit appeared first on BioAegis Therapeutics.

September 18-19, 2024: MedInvest Biotech & Pharma Investor Conference

Susan Serrao — Thu, 05 Sep 2024 18:13:09 +0000

BioAegis co-founder, Steve Cordovano, was invited to present at the upcoming MedInvest Biotech & Pharma Investor Conference in New York City. The presentation, “Conquering Disease Driven by Excess Inflammation” will highlight BioAegis’ novel, host-directed immune regulator protein. The presentation will also discuss BioAegis’ lead indication, Acute Respiratory Distress Syndrome (ARDS), and its phase 2 global […]

The post September 18-19, 2024: MedInvest Biotech & Pharma Investor Conference appeared first on BioAegis Therapeutics.

May 23, 2023: Below the Eyes of the Hippopotamus: The Expanding Spectrum of Auto- and Hyper- Inflammatory Diseases

Susan Serrao — Fri, 12 May 2023 22:43:13 +0000

BioAegis sponsored webinar, Below the Eyes of the Hippopotamus: The Expanding Spectrum of Auto- and Hyper- Inflammatory Diseases will delve beneath the surface of this rapidly growing field of auto-inflammatory and hyper-inflammatory diseases. It will explore what we know and will need to know moving forward, in particular: How these diseases of the innate immune […]

The post May 23, 2023: Below the Eyes of the Hippopotamus: The Expanding Spectrum of Auto- and Hyper- Inflammatory Diseases appeared first on BioAegis Therapeutics.

November 12, 2021: Belgium MACRO Trends Investors Conference

Susan Serrao — Thu, 21 Oct 2021 21:59:31 +0000

BioAegis co-founders were selected to present at the upcoming MACRO Trends Investors Conference in Belgium. The presentation, “Conquering Pneumonia and Systemic Inflammation,” will highlight BioAegis’ novel, host-directed treatment. About MACRO Trends MACRO Trends is a Dutch Investment advisory firm centered around a regularly published magazine edited by Brecht Arnaert, a monetary expert at the Rey […]

The post November 12, 2021: Belgium MACRO Trends Investors Conference appeared first on BioAegis Therapeutics.

October 6-7, 2020: BioNJ’s 10th Annual BioPartnering Conference

Susan Serrao — Tue, 29 Sep 2020 17:32:00 +0000

Virtual Conference: Navigating Unprecedented Global Uncertainty Tuesday, October 6th and Wednesday, October 7th 2020 Developed with J.P. Morgan and Johnson & Johnson Innovation, BioNJ’s Virtual Two-Day BioPartnering Conference will bring together life sciences professionals from the Northeast and beyond. Last year’s Conference convened attendees representing 17 states and 5 countries. Come ready to meet investors, industry executives and partnering professionals; […]

The post October 6-7, 2020: BioNJ’s 10th Annual BioPartnering Conference appeared first on BioAegis Therapeutics.

August 20, 2020: WIB-Metro New York – Biotech Leadership in the time of COVID-19: Impact, Opportunity, and Resilience

serrao6 — Thu, 20 Aug 2020 18:09:00 +0000

The leadership team of BioAegis Therapeutics will share their experiences this year as they reframed their strategy to address the COVID-19 threat to their employees and hustled to initiate a COVID-19 clinical trial for severe COVID-19 patients. When: Thursday, August 20, 2020 12:00 p.m. – 1:00 p.m. EDT Where: Online (GoToWebinar) Contact: WIB-Metro New York […]

The post August 20, 2020: WIB-Metro New York – Biotech Leadership in the time of COVID-19: Impact, Opportunity, and Resilience appeared first on BioAegis Therapeutics.

June 5, 2020: BioNJ COVID-19 Rapid Fire Research Showcase

serrao6 — Fri, 05 Jun 2020 11:12:32 +0000

BioAegis has been selected as a featured company in the upcoming BioNJ COVID-19 Rapid Fire Research Showcase. Our Chief Executive Officer and Co-founder, Dr. Susan Levinson, will present our goundbreaking recombinant human plasma gelsolin (rhu-pGSN) therapy. WHEN: Friday, June 5, 2020, 9:00 a.m. – 10:00 a.m. Register Now

The post June 5, 2020: BioNJ COVID-19 Rapid Fire Research Showcase appeared first on BioAegis Therapeutics.